Dentists in Ridgeland, SC Accepting Medicare
8 Dentists found. Showing 1 - 8
 Dr. Monica Denise Dawson, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 721 N Okatie Hwy, Ridgeland, SC 29936 Phone: 843-987-7400 |
 Dr. Starling Speed Ray Iii, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 721 Okatie Hwy170, Ridgeland, SC 29936 Phone: 843-987-7400 Fax: 843-987-7498 |
Dr. Tyese Wright, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 10832 N Jacob Smart Blvd, Ridgeland, SC 29936 Phone: 843-726-5711 |
Dr. Earl Bostick Sr., DMD Dentist Medicare: Medicare Enrolled Practice Location: 110 Jacob Smart Blvd., Ridgeland, SC 29936 Phone: 843-726-5711 |
Dr. Janet Ann Stoddart, DDS Dentist Medicare: Medicare Enrolled Practice Location: Beaufort Jasper Hampton Comprehensive Health Services, 721 N Okatie Hwy, 357, Ridgeland, SC 29936 Phone: 843-987-7400 Fax: 843-987-3104 |
Kelvin Bostick, D.D.S Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 10832 N Jacob Smart Blvd, Ridgeland, SC 29936 Phone: 843-726-5711 |
Dr. Marc Wooster, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 591 Browns Cove Rd Ste A, Ridgeland, SC 29936 Phone: 843-645-7844 |
Mr. Jay Scott Wooster, DDS Dentist Medicare: Medicare Enrolled Practice Location: 591 Browns Cove Rd, Unit A, Ridgeland, SC 29936 Phone: 843-645-7844 Fax: 843-645-7846 |
News Archive
Aetna, Glens Falls Hospital announce new multiyear agreement
Glens Falls Hospital and Aetna today announced a new multiyear agreement. Glens Falls will remain an "in-network" provider of care for Aetna members.
Magellan Health Services announces financial results for second quarter 2013
Magellan Health Services Inc. today reported financial results for the second quarter 2013, as summarized below. For the quarter ended June 30, 2013, the company reported net revenue of $842.7 million, segment profit of $75.0 million, and net income of $31.5 million or $1.15 per diluted common share.
Treatment using PARP inhibitor shrinks tumors in breast cancer patients with BRCA mutations
All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson Cancer Center.
Prophylactic antibiotics reduce risk of serious bacterial infections in children with ALL
Prophylactic antibiotics significantly reduce the risk of serious bacterial infections in children during the critical first month of treatment for acute lymphoblastic leukemia (ALL), the most common childhood cancer, according to a U.S. and Canadian study led by investigators from Dana-Farber/Boston Children's Cancer and Blood Disorders Center.
Cytrx's study offers a better perception of arimoclomol's mechanism of action in induced animal stroke
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that study results demonstrated that arimoclomol exhibited both statistically significant neuroprotective and neuroregenerative effects in brain cells of animals induced with stroke, offering important insights into this drug candidate's mechanism of action.
› Verified 7 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Occupational Therapists
Psychologists